Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial

Author:

Chow Clara K.12ORCID,Klimis Harry12ORCID,Thiagalingam Aravinda12,Redfern Julie3ORCID,Hillis Graham S.45ORCID,Brieger David6ORCID,Atherton John78,Bhindi Ravinay39,Chew Derek P.10ORCID,Collins Nicholas11,Andrew Fitzpatrick Michael3,Juergens Craig1213,Kangaharan Nadarajah101415,Maiorana Andrew1617ORCID,McGrady Michele318,Poulter Rohan19,Shetty Pratap20,Waites Jonathon21,Hamilton Craig Christian822,Thompson Peter42324,Stepien Sandrine25ORCID,Von Huben Amy1ORCID,Rodgers Anthony1,

Affiliation:

1. Westmead Applied Research Institute (C.K.C., H.K., A.T., A.V.H., A.R.), University of Sydney, Australia.

2. Department of Cardiology, Westmead Hospital, Sydney, Australia (C.K.C., H.K., A.T.).

3. Faculty of Medicine and Health (J.R., R.B., M.A.F., M.M.), University of Sydney, Australia.

4. University of Western Australia, Perth (G.S.H., P.T.).

5. Department of Cardiology, Royal Perth Hospital, Australia (G.S.H.).

6. ANZAC Research Institute (D.B.), University of Sydney, Australia.

7. Department of Cardiology, Royal Brisbane and Women’s Hospital, Brisbane, Australia (J.A.).

8. The University of Queensland, Brisbane, Australia (J.A., C.H.C.).

9. Department of Cardiology, Royal North Shore Hospital, Sydney, Australia (R.B.).

10. College of Medicine and Public Health, Flinders University, Adelaide, South Australia (D.P.C., N.K.).

11. Hunter Medical Research Institute, Newcastle, Australia (N.C.).

12. Faculty of Medicine, The University of New South Wales, Sydney, Australia (C.J.).

13. Department of Cardiology, Liverpool Hospital, Sydney, Australia (C.J.).

14. Department of Cardiology, Royal Darwin Hospital, Darwin, Australia (N.K.).

15. Menzies School of Health Research, Darwin, Australia (N.K.).

16. Allied Health Department, Fiona Stanley Hospital, Perth, Australia (A.M.).

17. School of Allied Health, Curtin University, Perth, Australia (A.M.).

18. Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia (M.M.).

19. Department of Cardiology, Sunshine Coast University Hospital, Brisbane, Australia (R.P.).

20. Department of Cardiology, Wollongong and Shellharbour Hospitals, Wollongong, Australia (P.S.).

21. Coffs Cardiology, Coffs Harbour, Australia (J.W.).

22. Department of Cardiology, Prince Charles Hospital, Brisbane, Australia (C.H.C.).

23. Department of Cardiology, Sir Charles Gairdner Hospital, Perth, Australia (P.T.).

24. Harry Perkins Institute of Medical Research, Perth, Australia (P.T.).

25. The George Institute for Global Health, Sydney, Australia (C.K.C., H.K., A.R., G.S.H., S.S., A.R.).

Abstract

Background: TEXTMEDS (Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome) examined the effects of text message–delivered cardiac education and support on medication adherence after an acute coronary syndrome. Methods: TEXTMEDS was a single-blind, multicenter, randomized controlled trial of patients after acute coronary syndrome. The control group received usual care (secondary prevention as determined by the treating clinician); the intervention group also received multiple motivational and supportive weekly text messages on medications and healthy lifestyle with the opportunity for 2-way communication (text or telephone). The primary end point of self-reported medication adherence was the percentage of patients who were adherent, defined as >80% adherence to each of up to 5 indicated cardioprotective medications, at both 6 and 12 months. Results: A total of 1424 patients (mean age, 58 years [SD, 11]; 79% male) were randomized from 18 Australian public teaching hospitals. There was no significant difference in the primary end point of self-reported medication adherence between the intervention and control groups (relative risk, 0.93 [95% CI, 0.84–1.03]; P =0.15). There was no difference between intervention and control groups at 12 months in adherence to individual medications (aspirin, 96% vs 96%; β-blocker, 84% vs 84%; angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, 77% vs 80%; statin, 95% vs 95%; second antiplatelet, 84% vs 84% [all P >0.05]), systolic blood pressure (130 vs 129 mm Hg; P =0.26), low-density lipoprotein cholesterol (2.0 vs 1.9 mmol/L; P =0.34), smoking ( P =0.59), or exercising regularly (71% vs 68%; P =0.52). There were small differences in lifestyle risk factors in favor of intervention on body mass index <25 kg/m 2 (21% vs 18%; P =0.01), eating ≥5 servings per day of vegetables (9% vs 5%; P =0.03), and eating ≥2 servings per day of fruit (44% vs 39%; P =0.01). Conclusions: A text message–based program had no effect on medical adherence but small effects on lifestyle risk factors. Registration: URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364448 ; Unique identifier: ANZCTR ACTRN12613000793718.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3